Morning Briefing
Summaries of health policy coverage from major news organizations
Costly New Hepatitis C Drug Raises Questions About Who Will Pay
The new hepatitis C medication presents a dilemma for Medicaid and other insurers, who must balance the cost against the large numbers of people who might benefit. A single course of treatment costs $84,000.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
